24 results on '"Ekberg, Jana"'
Search Results
2. #1985 Tocilizumab in chronic active antibody-mediated rejection: a randomized controlled open-label multi-center trial (INTERCEPT study)
3. A Randomized Controlled Trial on Safety of Steroid Avoidance in Immunologically Low-Risk Kidney Transplant Recipients
4. Immunosuppression and Treatment of Rejection in Uterus Transplantation: Current Practice and Future Potential
5. Uterus transplantation: Histological findings in explants at elective hysterectomy
6. Difficult-to-Treat Rejections in Kidney Transplant Recipients: Our Experience with Everolimus-Based Quadruple Maintenance Therapy
7. Long-term Course of Kidney Function in Uterus Transplant Recipients Under Treatment With Tacrolimus and After Transplantectomy: Results of the First Clinical Cohort
8. Immunosuppression and Treatment of Rejection in Uterus Transplantation: Current Practice and Future Potential
9. Initial Report From a Swedish High-Volume Transplant Center After The First Wave of The COVID-19 Pandemic
10. Livebirth after uterus transplantation
11. Effects of Corticosteroid Treatment on Mycophenolic Acid Exposure in Renal Transplant Patients—Results From the SAILOR Study
12. The costs of human uterus transplantation: a study based on the nine cases of the initial Swedish live donor trial
13. Outcome of Recipient Surgery and 6-Month Follow-Up of the Swedish Live Donor Robotic Uterus Transplantation Trial
14. Live birth after robotic‐assisted live donor uterus transplantation
15. Initial Inhibition of Tissue Factor Signalling Reduces Chronic Vascular Changes in Isogenic Rat Aortic Transplants
16. The costs of human uterus transplantation: a study based on the nine cases of the initial Swedish live donor trial.
17. TO017PRE-TRANSPLANT ASSESSMENT OF KSORTSM: A MEASURE TO ASSESS RISK FOR REJECTION IN SENSITIZED PATIENTS
18. One uterus bridging three generations: first live birth after mother-to-daughter uterus transplantation
19. Live Birth After Uterus Transplantation
20. A study of clinical complications and risk factors in 1001 native and transplant kidney biopsies in Sweden
21. An in-progress, open-label, multi-centre study (SAILOR) evaluating whether a steroid-free immunosuppressive protocol, based on ATG induction and a low tacrolimus dose, reduces the incidence of new onset diabetes after transplantation
22. Serum Cystatin C Is a More Sensitive and More Accurate Marker of Glomerular Filtration Rate than Enzymatic Measurements of Creatinine in Renal Transplantation
23. A Randomized Controlled Trial on Safety of Steroid Avoidance in Immunologically Low-Risk Kidney Transplant Recipients.
24. Initial Report From a Swedish High-volume Transplant Center After the First Wave of the COVID-19 Pandemic.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.